Long-Term Efficacy of Photodynamic Therapy with Fractionated 5-Aminolevulinic Acid 20% versus Conventional Two-Stage Topical Methyl Aminolevulinate for Superficial Basal-Cell Carcinoma.

Autor: van Delft LCJ; Department of Dermatology, Maastricht University Medical Center, Maastricht, The Netherlands.; GROW School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands., Nelemans PJ; Department of Epidemiology, Maastricht University, Maastricht, The Netherlands., Kessels JPHM; Department of Dermatology, Zuyderland Hospital, Heerlen, The Netherlands., Kreukels H; Dermatology Clinic, De Blaak, Rotterdam, The Netherlands., Roozeboom MH; Department of Dermatology, Elkerliek Hospital, Helmond, The Netherlands., de Rooij MJM; Department of Dermatology, Viecuri Medical Center, Venlo, The Netherlands., Mosterd K; Department of Dermatology, Maastricht University Medical Center, Maastricht, The Netherlands.; GROW School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands., de Haas ERM; Department of Dermatology, Erasmus Medical Center, Rotterdam, The Netherlands.; Department of Dermatology, Havenziekenhuis, Rotterdam, The Netherlands., Kelleners-Smeets NWJ; Department of Dermatology, Maastricht University Medical Center, Maastricht, The Netherlands.; GROW School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.

Publikováno v: Dermatology (Basel, Switzerland) [Dermatology] 2022; Vol. 238 (6), pp. 1044-1049. Date of Electronic Publication: 2022 May 20.

Comparison of long-term cosmetic outcomes for different treatments of superficial basal cell carcinoma.

Autor: Jansen MHE; Department of Dermatology, Maastricht University Medical Centre, Maastricht, the Netherlands; GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands. Electronic address: maud.jansen@mumc.nl., Koekelkoren FHJ; Department of Dermatology, Maastricht University Medical Centre, Maastricht, the Netherlands., Nelemans PJ; Department of Epidemiology, Maastricht University Medical Centre, Maastricht, the Netherlands., Arits AHMM; Department of Dermatology, Maastricht University Medical Centre, Maastricht, the Netherlands; GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands; Department of Dermatology, Catharina Hospital, Eindhoven, the Netherlands., Roozeboom MH; Department of Dermatology, Elkerliek Hospital, Helmond, the Netherlands., Kelleners-Smeets NWJ; Department of Dermatology, Maastricht University Medical Centre, Maastricht, the Netherlands; GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands., Mosterd K; Department of Dermatology, Maastricht University Medical Centre, Maastricht, the Netherlands; GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands.

Publikováno v: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2018 Nov; Vol. 79 (5), pp. 961-964. Date of Electronic Publication: 2018 May 10.

Five-Year Results of a Randomized Controlled Trial Comparing Effectiveness of Photodynamic Therapy, Topical Imiquimod, and Topical 5-Fluorouracil in Patients with Superficial Basal Cell Carcinoma.

Autor: Jansen MHE; Department of Dermatology, Maastricht University Medical Centre, Maastricht, The Netherlands; GROW Research Institute for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands. Electronic address: maud.jansen@mumc.nl., Mosterd K; Department of Dermatology, Maastricht University Medical Centre, Maastricht, The Netherlands; GROW Research Institute for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands., Arits AHMM; Department of Dermatology, Maastricht University Medical Centre, Maastricht, The Netherlands; GROW Research Institute for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands; Department of Dermatology, Catharina Hospital, Eindhoven, The Netherlands., Roozeboom MH; Department of Dermatology, Maastricht University Medical Centre, Maastricht, The Netherlands; GROW Research Institute for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands., Sommer A; Department of Dermatology, Parkweg Clinic Sommer, Maastricht, The Netherlands., Essers BAB; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht, The Netherlands., van Pelt HPA; Department of Dermatology, VieCuri Medical Centre, Venlo, The Netherlands., Quaedvlieg PJF; Department of Dermatology, Zuyderland Medical Centre, Heerlen, The Netherlands., Steijlen PM; Department of Dermatology, Maastricht University Medical Centre, Maastricht, The Netherlands; GROW Research Institute for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands; Department of Dermatology, Catharina Hospital, Eindhoven, The Netherlands., Nelemans PJ; Department of Epidemiology, Maastricht University, Maastricht, The Netherlands., Kelleners-Smeets NWJ; Department of Dermatology, Maastricht University Medical Centre, Maastricht, The Netherlands; GROW Research Institute for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.

Publikováno v: The Journal of investigative dermatology [J Invest Dermatol] 2018 Mar; Vol. 138 (3), pp. 527-533. Date of Electronic Publication: 2017 Oct 16.

Subtyping basal cell carcinoma by clinical diagnosis versus punch biopsy.

Autor: Roozeboom MH; Department of Dermatology, Maastricht University Medical Centre, P. Debyelaan 25, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands. mh.roozeboom@mumc.nl., Kreukels H, Nelemans PJ, Mosterd K, Winnepenninckx VJ, Abdul Hamid MA, de Haas ER, Kelleners-Smeets NW

Publikováno v: Acta dermato-venereologica [Acta Derm Venereol] 2015 Nov; Vol. 95 (8), pp. 996-8.

Tumor thickness and adnexal extension of superficial basal cell carcinoma (sBCC) as determinants of treatment failure for methylaminolevulinate (MAL)-photodynamic therapy (PDT), imiquimod, and 5-fluorouracil (FU).

Autor: Roozeboom MH; Department of Dermatology, Maastricht University Medical Center, Maastricht, The Netherlands; GROW Research Institute for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands. Electronic address: mh.roozeboom@mumc.nl., van Kleef L; Department of Dermatology, Maastricht University Medical Center, Maastricht, The Netherlands., Arits AH; Department of Dermatology, Maastricht University Medical Center, Maastricht, The Netherlands; GROW Research Institute for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands., Mosterd K; Department of Dermatology, Maastricht University Medical Center, Maastricht, The Netherlands; GROW Research Institute for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands., Winnepenninckx VJ; Department of Pathology, Maastricht University Medical Center, Maastricht, The Netherlands., van Marion AM; Department of Pathology, VieCuri Medical Center, Venlo, The Netherlands., Nelemans PJ; Department of Epidemiology, Maastricht University, Maastricht, The Netherlands., Kelleners-Smeets NW; Department of Dermatology, Maastricht University Medical Center, Maastricht, The Netherlands; GROW Research Institute for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.

Publikováno v: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2015 Jul; Vol. 73 (1), pp. 93-8. Date of Electronic Publication: 2015 Apr 30.